About 100 reports

Irritable Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Drugs In Development, 2021, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Irritable...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Drug Development
  • World
  • South Korea
  • Ghana
  • Medical Technology Density
  • Drug Approval

The gastrointestinal drugs market was valued at US$ 49,043.38 million in 2019 and is projected to reach US$ 71,300.28 million by 2027; it is expected to grow at a CAGR of 4.9% from 2020 to 2027. The growth of the gastrointestinal drugs market is mainly attributed to factors such as rise in prevalence of gastrointestinal (GI) diseasesand...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • In-Store Retail
  • World
  • APAC
  • Europe
  • North America
  • Middle East
  • Drug Approval
  • Health Expenditure

The Europe gastrointestinal drugs market is expected to reach US$ 17,810.81 million by 2027 from US$ 12,721.85 million in 2019; it is expected to grow at a CAGR of 4.4% from 2020 to 2027. Rising prevalence of gastrointestinal (GI) diseases and increase in development of biologics are expected to boost the growth of the market. However, factors...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • In-Store Retail
  • Europe
  • Drug Approval
  • Biosimilar Approvals

Major companies in the gastrointestinal drugs market include Takeda Pharmaceuticals, Bayer AG, Abbott Laboratories, Otsuka Holdings Co. ltd., Johnson & Johnson, Reckitt Benckiser Group plc., Bausch Health Companies Inc., Sanofi S.A, Procter & Gamble and Daiichi Sankyo Company. The global gastrointestinal drugs market is expected to...

  • Pharmaceutical
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmacy
  • World
  • Middle East
  • United States
  • APAC
  • Health Expenditure

Market Introduction Gastrointestinal drugs include promotility drugs, antimotility drugs, and drugs for acid-related disorders.The generally used gastrointestinal drugs as a group are considered safe. Gastrointestinal (GI) disease affects the stomach, pancreas, rectum and large intestine, esophagus, small intestine, gallbladder,...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • In-Store Retail
  • North America
  • Drug Approval
  • Use Of Prescription Drugs

Constipation (Gastrointestinal) - Drugs in Development, 2021 Summary Constipation (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Constipation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Constipation,...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Research And Development
  • Drug Development
  • World

Market Introduction Gastrointestinal drugs include promotility drugs, antimotility drugs, and drugs for acid-related disorders.The generally used gastrointestinal drugs as a group are considered safe. Gastrointestinal (GI) disease affects the stomach, pancreas, rectum and large intestine, esophagus, small intestine, gallbladder,...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • In-Store Retail
  • Middle East
  • Africa
  • Drug Approval
  • Health Expenditure

The South and Central America gastrointestinal drugs market is expected to reach US$ 5,632.72 million by 2027 from US$ 4,160.28 million in 2019; it is expected to grow at a CAGR of 4.0% from 2020 to 2027. Rising prevalence of gastrointestinal (GI) diseases and increase in development of biologics are expected to boost the growth of the market....

  • Gastrointestinal Drug
  • Digestive System Disorder
  • In-Store Retail
  • Central America
  • Drug Approval
  • Health Expenditure

Diarrhea (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Drugs in Development, 2021, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape. Diarrhea is a contagious gastrointestinal infection...

  • Pharmaceutical
  • Gastrointestinal Drug
  • Digestive System Disorder
  • World
  • United States
  • Drug Approval
  • HIV AIDS Prevalence

Infectious Diarrhea (Gastrointestinal) - Drugs in Development, 2021 Summary Infectious Diarrhea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Infectious Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Research And Development
  • World

Traveler’s Diarrhea (Gastrointestinal) - Drugs in Development, 2021 Summary Traveler’s Diarrhea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Traveler’s Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • Research And Development
  • World

Gastrointestinal Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists; marketers and senior management with the critical information they need to assess the global gastrointestinal drugs market as it emerges from the COVID 19 shut down. Description: Where is...

  • Pharmaceutical
  • In-Store Retail
  • Gastrointestinal Drug
  • World

Major players in the gastrointestinal bleeding treatment devices market are CONMED, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris Plc, and Pfizer Inc. The global gastrointestinal bleeding treatment devices market is expected to grow from...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Japan

Major companies in the gastrointestinal drugs market include Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc and Johnson & Johnson. The global gastrointestinal drugs market is expected to grow from $46.68 billion in 2020 to $48.74 billion in 2021 at a compound annual growth rate (CAGR) of 4.4%. The change in growth...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Health Expenditure
  • Population Over Age Of 65

Abstract: - Global Portable Monitoring Devices Market to Reach $35.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Portable Monitoring Devices estimated at US$23.9 Billion in the year 2020, is projected to reach a revised size of US$35.5 Billion by 2027, growing at a CAGR of 5.8% over the analysis...

  • Neurology
  • Gastrointestinal Drug
  • World
  • China
  • United States

Reflux Esophagitis (Gastroesophageal Reflux Disease) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis - Drugs in Development, 2021, provides an overview of the Reflux Esophagitis (Gastrointestinal) pipeline...

  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • China
  • South Korea
  • Pharmaceutical Registrations
  • Medical Technology Density

Irritable Bowel Syndrome - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2020, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape. Irritable bowel syndrome...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • World
  • United States
  • North America
  • Medical Technology Density
  • HIV AIDS Prevalence

Global Gastrointestinal Stents Market 2021-2025 The analyst has been monitoring the gastrointestinal stents market and it is poised to grow by $ 99.61 mn during 2021-2025, decelerating at a CAGR of 6.41% during the forecast period. Our report on the gastrointestinal stents market provides a holistic analysis, market size...

  • Gastrointestinal Drug
  • Marketing Research
  • World
  • India

Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Pharmaceutical
  • World
  • Child Mortality
  • Drug Approval

Reflux Esophagitis (Gastroesophageal Reflux Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis (Gastroesophageal Reflux Disease) - Drugs in Development...

  • Gastrointestinal Drug
  • World
  • South Korea
  • China
  • Pharmaceutical Exports

Irritable Bowel Syndrome - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome – Pipeline Review, H1 2020, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape. Irritable bowel...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • World
  • Ghana
  • Drug Approval
  • Medical Technology Density

Executive Summary Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market was valued at USD 5.5 billion in the year 2020. The key factors driving growth in the global Gastroesophageal Reflux Disease Therapeutics market is increased public awareness of the disease and its symptoms. The growing incidence of heartburn...

  • Gastrointestinal Drug
  • Therapy
  • World
  • APAC
  • Health Expenditure
  • Gross Domestic Product

Microbiome - Targeted Therapeutics in Immunology - Thematic Research Summary The microbiome is considered the genetic material of all microorganisms existing in and on the human body.Large resident microbial communities exist in the gastrointestinal (GI) tract, skin, and respiratory tract, and...

  • Pharmaceutical
  • Therapy
  • Dermatological Condition
  • Gastrointestinal Drug
  • Targeted Therapy
  • Clinical Trial
  • Acne Treatment
  • United States
  • Asthma Prevalence
  • Drug Approval

The Europe antacids market is expected to reach US$ 3,396.21 million in 2027 from US$ 2,438.49 million in 2019. The market is estimated to grow at a CAGR of 4.3% during 2020–2027. The growth of the Europe antacids market is attributed to the key driving factors such as the rising prevalence of gastrointestinal diseases and the increasing...

  • Gastrointestinal Drug
  • Europe
  • Pharmaceutical Exports
  • Number Of Enterprises

Major players in the digestive enzymes market are Garden of Life, Biotics Research Corporation, Klaire Laboratories, Abbott Nutrition, AbbVie Inc., Allergan PLC, Johnson & Johnson Inc., Amway Corporation, Food State Inc., Matsun Nutrition and Metagenics Inc. The global digestive enzymes market is expected to grow from $0.44 billion...

  • Gastrointestinal Drug
  • World
  • United States
  • APAC

Major players in the digestive enzymes market are Garden of Life, Biotics Research Corporation, Klaire Laboratories, Abbott Nutrition, AbbVie Inc., Allergan PLC., Johnson & Johnson Inc. Amway Corporation, Food State Inc., Matsun Nutrition, Metagenics Inc., Twinlab Corporation, Food State Inc., AST Enzymes, VEMO 99 OOD, Advanced Vital Enzymes...

  • Gastrointestinal Drug
  • World
  • Middle East
  • United States
  • APAC

The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2020 to 2028. Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Diagnostics
  • APAC
  • World
  • Europe
  • Diagnostic Revenue
  • Drug Approval

Diarrhea - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Pipeline Review, H2 2020, provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape. Diarrhea is a contagious gastrointestinal infection occurring mostly...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • United States
  • HIV AIDS Prevalence
  • Manufacturing Output

Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Reflux Esophagitis - Pipeline Review, H2 2020, provides an overview of the Reflux Esophagitis (Gastrointestinal) pipeline landscape. When...

  • Gastrointestinal Drug
  • World
  • China
  • South Korea
  • Pharmaceutical Registrations
  • Medical Technology Density

The North America irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 1,529.08 million by 2028 from US$ 950.83 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome...

  • Gastrointestinal Drug
  • Digestive System Disorder
  • Diagnostics
  • United States
  • North America
  • Canada
  • Drug Approval
  • Diagnostic Revenue